# Postoperative Pain Control in AIS Using Liposomal Bupivacaine vs. 0.25% Bupivacaine With Epinephrine

> **NCT06471348** · NA · RECRUITING · sponsor: **Boston Children's Hospital** · enrollment: 128 (estimated)

## Conditions studied

- Post Operative Pain
- Spinal Fusion

## Interventions

- **DRUG:** Bupivacaine liposome injectable suspension
- **DRUG:** Bupivacaine Hydrochloride and Epinephrine Injection

## Key facts

- **NCT ID:** NCT06471348
- **Lead sponsor:** Boston Children's Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-15
- **Primary completion:** 2027-08-15
- **Final completion:** 2028-08-31
- **Target enrollment:** 128 (ESTIMATED)
- **Last updated:** 2025-10-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06471348

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06471348, "Postoperative Pain Control in AIS Using Liposomal Bupivacaine vs. 0.25% Bupivacaine With Epinephrine". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT06471348. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*